James E. Mills

2.0k citations

36 papers · 1.1k indexed · h-index 18

Impact in

Computational Theory and Mathematics top 2%
- Computational Drug Discovery Methods
Organic Chemistry top 10%

Papers in ⓘ

Molecular Biology 16
- Receptor Mechanisms and Signaling 4
- Chemical Synthesis and Analysis 4
- Protein Structure and Dynamics 3
Computational Theory and Mathematics 11
- Computational Drug Discovery Methods 11

Co-authors: P. M. Dean (4 shared papers)John F. Murray (1 shared paper)Timothy D. Perkins (4 shared papers)Lyn H. Jones (2 shared papers)Nigel A. Swain (1 shared paper)Hualin Simon Xi (1 shared paper)Bruce A. Posner (1 shared paper)Gavin A. Whitlock (4 shared papers)
Journals: Journal of Computer-Aided Molecular Design (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Medicinal Chemistry (4 papers)MedChemComm (3 papers)Molecular Diversity (2 papers)
Partner nations: United Kingdom United States Switzerland

In The Last Decade

James E. Mills

35 papers receiving 1.1k citations

Peers

Countries citing papers authored by James E. Mills

Since Specialization

Citations

This map shows the geographic impact of James E. Mills's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Mills with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Mills more than expected).

Fields of papers citing papers by James E. Mills

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Mills. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Mills. The network helps show where James E. Mills may publish in the future.

Co-authors

The 25 scholars most cited alongside James E. Mills, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James E. Mills Line = papers co-authored together James E. Mills links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Three-dimensional hydrogen-bond geometry and probability information from a crystal survey Journal of Computer-Aided Molecular Design ·James E. Mills, P. M. Dean	1996	205
2	Rapid Discovery of a Novel Series of Abl Kinase Inhibitors by Application of an Integrated Microfluidic Synthesis and Screening Platform Journal of Medicinal Chemistry ·Bimbisar Desai, Karen Dixon, Elizabeth Farrant, Qixing Feng, Karl R. Gibson, Willem P. van Hoorn, James E. Mills, Trevor Morgan, David M. Parry, Manoj K. Ramjee, Christopher N. Selway, Gary J. Tarver, Gavin A. Whitlock, Adrian G. Wright	2013	102
3	Pulmonary Infectious Complications of Human Immunodeficiency Virus Infection: Part II American Review of Respiratory Disease ·John F. Murray, James E. Mills	1990	83
4	Selective Inhibitors of Protozoan Protein N-myristoyltransferases as Starting Points for Tropical Disease Medicinal Chemistry Programs PLoS neglected tropical diseases ·Andrew Bell, James E. Mills, Gareth Williams, J.A. Brannigan, Anthony J. Wilkinson, Tanya Parkinson, Robin J. Leatherbarrow, Edward W. Tate, Anthony A. Holder, Deborah F. Smith	2012	72
5	Aromatic chloride to nitrile transformation: medicinal and synthetic chemistry MedChemComm ·Lyn H. Jones, Nicholas W. Summerhill, Nigel A. Swain, James E. Mills	2010	72
6	High-Throughput Virtual Screening of Proteins Using GRID Molecular Interaction Fields Journal of Chemical Information and Modeling ·Simone Sciabola, Robert V. Stanton, James E. Mills, Maria M. Flocco, Massimo Baroni, Gabriele Cruciani, Francesca Perruccio, Jonathan Mason	2009	64
7	Novel Amino-pyrazole Ureas with Potent In Vitro and In Vivo Antileishmanial Activity Journal of Medicinal Chemistry ·Charles E. Mowbray, Stéphanie Braillard, William C. Speed, Paul A. Glossop, Gavin A. Whitlock, Karl R. Gibson, James E. Mills, Alan D. Brown, Mark Gardner, Yafeng Cao, Wen Jin Hua, Garreth L. Morgans, Pim‐Bart Feijens, An Matheeussen, Louis Maes	2015	51
8	Enhanced HTS Hit Selection via a Local Hit Rate Analysis Journal of Chemical Information and Modeling ·Bruce A. Posner, Hualin Simon Xi, James E. Mills	2009	42
9	Molecular surface-volume and property matching to superpose flexible dissimilar molecules Journal of Computer-Aided Molecular Design ·Timothy D. Perkins, James E. Mills, P. M. Dean	1995	38
10	Design of a multi-purpose fragment screening library using molecular complexity and orthogonal diversity metrics Journal of Computer-Aided Molecular Design ·Wan F. Lau, Jane M. Withka, David Hepworth, Thomas V. Magee, Yuhua J. Du, Gregory A. Bakken, Michael D. Miller, Zachary Hendsch, V. Thanabal, Steve A. Kolodziej, Xing Li, Qiyue Hu, Lakshmi Narasimhan, Robert A. Love, Maura E. Charlton, Samantha Jane Hughes, Willem P. van Hoorn, James E. Mills	2011	38
11	Dynamic spectrum matching with one-shot learning Chemometrics and Intelligent Laboratory Systems ·Jinchao Liu, Stuart Gibson, James E. Mills, Margarita Osadchy	2018	36
12	Development of a Pharmacophore Model for Histamine H₃ Receptor Antagonists, Using the Newly Developed Molecular Modeling Program SLATE Journal of Medicinal Chemistry ·Iwan J. P. de Esch, James E. Mills, Timothy D. Perkins, Giuseppe Romeo, Marcel Hoffmann, Kerstin Wieland, Rob Leurs, Wiro M. P. B. Menge, Paul H. J. Nederkoorn, Philip M. Dean, Henk Timmerman	2001	35
13	Continuing analysis of microRNA origins Mobile Genetic Elements ·Justin T. Roberts, Elvera A Cooper, Connor J Favreau, J. Howell, Lee G Lane, James E. Mills, Derrick C Newman, Tabitha J Perry, Meaghan E Russell, Brittany M Wallace, Glen M. Borchert	2013	32
14	Trypanosoma brucei Glycogen Synthase Kinase-3, A Target for Anti-Trypanosomal Drug Development: A Public-Private Partnership to Identify Novel Leads PLoS neglected tropical diseases ·Richard Oduor, Kayode K. Ojo, Gareth Williams, François Bertelli, James E. Mills, Louis Maes, David C. Pryde, Tanya Parkinson, Wesley C. Van Voorhis, Tod P. Holler	2011	27
15	Pyrazole NNRTIs 3: Optimisation of physicochemical properties Bioorganic & Medicinal Chemistry Letters ·Charles E. Mowbray, Romuald Corbau, Michael L. Hawes, Lyn H. Jones, James E. Mills, Manos Perros, Matthew D. Selby, Paul A. Stupple, Rob Webster, Anthony Wood	2009	24
16	slate: A method for the superposition of flexible ligands Journal of Computer-Aided Molecular Design ·James E. Mills, Iwan J. P. de Esch, Timothy D. Perkins, P. M. Dean	2001	23
17	The Pandemic Response Box─Accelerating Drug Discovery Efforts after Disease Outbreaks ACS Infectious Diseases ·Kirandeep Samby, Dominique Besson, Anirban Dutta, Buddhadev Patra, Angelique Doy, Paul A. Glossop, James E. Mills, Gavin A. Whitlock, Rob Hooft van Huijsduijnen, Alessandra Monaco, Graeme Bilbe, Charles E. Mowbray, Benjamin Perry, Anna Adam, Timothy N. C. Wells, Paul Willis	2022	20
18	Succinyl hydroxamates as potent and selective non-peptidic inhibitors of procollagen C-proteinase: Design, synthesis, and evaluation as topically applied, dermal anti-scarring agents Bioorganic & Medicinal Chemistry Letters ·Simon Bailey, Paul V. Fish, Stephane Billotte, Jon Bordner, Doris Greiling, Kim James, Andrew B. McElroy, James E. Mills, Charlotte Reed, Robert O. Webster	2008	19
19	SAR mining and its application to the design of TRPA1 antagonists MedChemComm ·James E. Mills, Alan D. Brown, Thomas Ryckmans, Duncan C. Miller, S. Skerratt, Carolyn M. Barker, Mark E. Bunnage	2011	15
20	Identification of false positives in “HTS hits to lead”: The application of Bayesian models in HTS triage to rapidly deliver a series of selective TRPV4 antagonists MedChemComm ·S. Skerratt, James E. Mills, Jayesh Mistry	2012	14

About James E. Mills

James E. Mills is a scholar working on Molecular Biology, Computational Theory and Mathematics, Organic Chemistry, Public Health, Environmental and Occupational Health and Epidemiology, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (11 papers), Receptor Mechanisms and Signaling (4 papers), Chemical Synthesis and Analysis (4 papers), Trypanosoma species research and implications (3 papers), Protein Structure and Dynamics (3 papers), Machine Learning in Materials Science (3 papers), Research on Leishmaniasis Studies (3 papers) and Malaria Research and Control (3 papers). The work is most often cited by research in Computational Theory and Mathematics (299 citations), Organic Chemistry (235 citations), Molecular Biology (534 citations), Virology (29 citations) and Biophysics (35 citations). James E. Mills has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include P. M. Dean, John F. Murray, Timothy D. Perkins, Lyn H. Jones, Nigel A. Swain, Hualin Simon Xi, Bruce A. Posner, Gavin A. Whitlock, Karl R. Gibson and Gareth Williams. Their work appears in journals such as Journal of Computer-Aided Molecular Design, Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, MedChemComm and Molecular Diversity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact